SPIO-MRI trial
Phase 2
Recruiting
- Conditions
- Breast cancer
- Registration Number
- JPRN-jRCTs051180046
- Lead Sponsor
- Kagara Naofumi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1.T1-2 primary breast cancer
2.Clinically negative axillary lymph node
3.Written informed consent
Exclusion Criteria
1.Contraindication of contrast agents
2.Pregnant, unwilling to practice contraception
3.Patients with serious complication
4.Doctor judges inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method axillary recurrence rate
- Secondary Outcome Measures
Name Time Method disease-free survival rate , overall survival rate